William James Adams
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$3.1MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $3.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Dec 7, 2022 | NIH | SBIR Phase I Pharmacological induction of KLF2 and reversal of endothelial dysfunction for the treatment of hypertension | $7K | RIPARIAN PHARMACEUTICALS INC |
| Apr 15, 2022 | NIH | SBIR Phase I Pharmacological induction of KLF2 and reversal of endothelial dysfunction for the treatment of hypertension | $311K | RIPARIAN PHARMACEUTICALS INC |
| Jun 7, 2018 | NIH | SBIR Phase II Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis | $698K | RIPARIAN PHARMACEUTICALS INC |
| May 25, 2017 | NIH | SBIR Phase II Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis | $1.2M | RIPARIAN PHARMACEUTICALS INC |
| Mar 15, 2017 | NIH | SBIR Phase II Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis | $20K | RIPARIAN PHARMACEUTICALS INC |
| Aug 20, 2016 | NIH | SBIR Phase II Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis | $857K | RIPARIAN PHARMACEUTICALS INC |
Peer ranks
Federal funding#576
Awards as PI#315
Patents#273
Companies
- RIPARIAN PHARMACEUTICALS INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.